COGZF.US Cogstate Limited

Healthcare Health Care Technology USA Stocks
2.43 USD
Close of Nov 13, 2026
1.26 2.57
Market cap
USD 419M
P/E
34.7x
P/B
7.60x
ROE
20.4%
Dividend yield
0.54%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is COGZF.US undervalued?

Graham number

The Graham number of Cogstate Limited cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cogstate Limited fundamental analysis

No fundamental analysis for Cogstate Limited yet.

Cogstate Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cogstate Limited

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. The company offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer's disease and dementia, preclinical Alzheimer's disease, …

Full company profile